新時達(002527.SZ):變更2個項目剩餘募集資金用途並永久補充流動資金
格隆匯1月20日丨新時達(002527.SZ)公佈,公司於2021年1月20日召開了第五屆董事會第七次會議及第五屆監事會第四次會議審議通過了《關於變更募集資金用途並永久補充流動資金的議案》,擬對公司2017年度公開發行可轉換公司債券募投項目中的“機器人及關鍵零部件與運動控制系統產品智能化製造項目”和“汽車智能化柔性焊接生產線生產項目”兩個項目的剩餘募集資金用途進行變更,並將上述募投項目餘額及理財收益和利息收入合計5.45億元(以實施補流時的募集資金賬户餘額為準)永久補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.